Full-Time
Posted on 9/4/2025
Global private markets investment manager
No salary listed
London, UK
In Person
Pantheon manages investments in private markets for a broad base of institutional and private clients. It raises and allocates capital to private equity, infrastructure and other private market strategies, offering flagship funds, integrated programs, and customized solutions. The approach uses a global network with offices in multiple major cities to source deals, diversify risk, and tailor investments for each client. Pantheon also oversees listed investment vehicles Pantheon International Plc (PIP) and Pantheon Infrastructure Plc (PINT) on the London Stock Exchange. As of 2022, it reported about $88.9 billion in assets under management and advice, and employed over 460 people worldwide. The goal is to grow client portfolios by providing access to a wide range of private market opportunities across geographies and stages, backed by experienced teams and scalable investment structures.
Company Size
201-500
Company Stage
Private
Total Funding
$379.4M
Headquarters
London, United Kingdom
Founded
1982
Help us improve and share your feedback! Did you find this helpful?
Hybrid Work Options
Professional Development Budget
QHP Capital has closed a $1.1 billion continuation vehicle for Azurity Pharmaceuticals, providing liquidity to existing investors whilst securing long-term capital for growth. The transaction was led by HarbourVest Partners, with Pantheon Ventures and Audax Strategic Capital participating. The deal, announced on 13 February 2026, allowed limited partners in QHP's selling fund to either take returns or roll proceeds into the continuation vehicle. Strong participation came from existing limited partners, whilst QHP's subsequent fund remains a significant investor. The capital will support Azurity's organic growth, business development, licensing and potential mergers and acquisitions. Azurity is a specialty pharmaceutical company with a portfolio of over 50 medicines spanning 10 therapeutic areas, distributed across more than 50 countries.
Eurazeo, a French investment company managing €37.4 billion in assets, has closed a €480 million private debt continuation vehicle with Pantheon, a global private markets investor. The transaction involves establishing a continuation fund and purchasing a diversified portfolio of high-performing European senior credit assets from Eurazeo's legacy private debt platforms. Under the structure, Eurazeo will continue managing the assets whilst Pantheon provides additional capital, enabling Eurazeo to support medium-sized European businesses. The continuation fund offers liquidity to private investors whilst maintaining underlying asset stability. Nicolas Nedelec, partner of Eurazeo's private debt team, said the transaction demonstrates the strength of their platform and commitment to proactively managing fund lifecycles in investors' best interests.
Curium and CapVest announce a $7B recapitalization - the largest transaction in nuclear medicine - to accelerate global innovation in diagnostic and therapeutic radiopharmaceuticals.
Pantheon raised $2.2 billion for its latest opportunistic credit secondaries fund, nearly tripling its initial target of $750 million. Overall, Pantheon has gathered $8.3 billion in its third fundraising round for senior and opportunistic credit funds. In April, the firm secured $5.2 billion for its flagship credit secondaries fund focused on senior debt. Rakesh Jain, global head of private credit, highlighted this as a validation of market opportunity and their track record.
DevCo Partners has secured €521 million in funding to support Vexve's next growth phase. The lead investor is Pantheon, with participation from North American and European family investment firms and institutional investors. About half of the funding comes from Vexve's current investors. The capital will aid Vexve's growth through organic means and acquisitions, driven by the accelerating energy transition.